1,596 hedge funds and large institutions have $95.7B invested in Amgen in 2017 Q1 according to their latest regulatory filings, with 151 funds opening new positions, 679 increasing their positions, 576 reducing their positions, and 71 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

4% more funds holding

Funds holding: 1,5371,596 (+59)

1.05% more ownership

Funds ownership: 78.07%79.12% (+1%)

33% less call options, than puts

Call options by funds: $1.14B | Put options by funds: $1.7B

Holders
1,596
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
79
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.14B
Puts
$1.7B
Net Calls
Net Calls Change

Top Buyers

1 +$7.63B
2 +$2.24B
3 +$584M
4
Barclays
Barclays
United Kingdom
+$245M
5
Goldman Sachs
Goldman Sachs
New York
+$161M

Top Sellers

1 -$1.34B
2 -$387M
3 -$149M
4
Primecap Management
Primecap Management
California
-$147M
5
O
OrbiMed
New York
-$147M
Name Holding Trade Value Shares
Change
Change in
Stake
1551
$35K
1552
$33K
1553
$33K
1554
$33K
1555
$33K
1556
$33K
1557
$31K
1558
$30K
1559
$27K
1560
$26K
1561
$25K
1562
$25K
1563
$22K
1564
$22K
1565
$22K
1566
$21K
1567
$19.5K
1568
$17K
1569
$16K
1570
$16K
1571
$16K
1572
$16K
1573
$15K
1574
$13K
1575
$11K